LON/0A77 (LON/0A77)

London Stock Exchange: LON/0A77 · USD

$296

-1.86 (-0.6%)· Recorded snapshot

Market cap	58.9B
Revenue (ttm)	212.8B
Net income (ttm)	4.8B
EPS (ttm)	$18.2
P/E (trailing)	12.2x
P/E (forward)	9.5x
Dividend	$4.70 (2.11%)
Volume	678
Beta	0.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 212.8B
Net income (ttm): 4.8B
EPS (ttm): $18.2
P/E (trailing): 12.2x
P/E (forward): 9.5x
Market cap: 58.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E9.5

P25 13.4P50 18.5P75 26.8

Trailing P/E12.2

P25 16.1P50 24.2P75 39.8

ROE16.8

P25 -48.7P50 3.8P75 15.3

ROIC13.4

P25 -35.4P50 4.3P75 12.3

Benchmarks · 1M

All LON/0A77 indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-11-05
Employees	66,685
Employees change	-5,800
Employees growth	-7.89%
Enterprise value	$77.7B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1792
Industry	Healthcare Plans
Is primary listing	No
ISIN number	US1255231003
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	$58.9B
Next earnings date	2026-11-05
Price	$296.40
Price currency	USD
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-28
Symbol	lon/0A77
Website	https://www.thecignagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	16.32x
Average P/E ratio (3Y)	18.63x
Average P/E ratio (5Y)	16.34x
Earnings yield	8.17%
EV/Earnings	16.12x
EV/EBIT	9.41x
EV/EBITDA	8.13x
EV/FCF	11.35x
EV/Sales	0.37x
FCF / EV yield	8.81%
FCF yield	11.6%
Forward P/E	9.51x
Graham number	298.70984
Graham upside	0.15%
Lynch fair value	$121.75
Lynch upside	-59.18%
P/B ratio	1.83x
P/E ratio	12.24x
P/FCF ratio	8.62x
P/OCF ratio	7.65x
P/S ratio	0.28x
Price/EBITDA ratio	6.16x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	3.9%
EBITDA margin	4.52%
Effective tax rate	19.17%
FCF margin	3.23%
Gross margin	9.14%
Operating margin	3.9%
Pretax margin	3.06%
Profit margin	2.27%
Profit per employee	$72,516
Profitable quarters	9
Profitable years	23
Revenue per employee	$3.2M
ROA	4.46%
ROA (5Y)	3.74%
ROCE	10.86%
ROE	16.76%
ROE (5Y)	12.28%
ROIC	13.39%
ROIC (5Y)	10.87%
Tax / revenue	0.59%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	32.61%
EPS growth (Q)	10.16%
EPS growth (QoQ)	0.48%
EPS growth 10Y	12.11%
EPS growth 3Y	3.06%
EPS growth 5Y	1.12%
EPS growth quarters	2
EPS growth years	1
FCF growth	131.06%
FCF growth 3Y	-7.23%
FCF growth 5Y	13.14%
Gross profit growth	-0.13%
Gross profit growth (Q)	6.07%
Gross profit growth 3Y	3.06%
Gross profit growth 5Y	2.25%
Net income growth	27.86%
Net income growth (Q)	8.36%
Net income growth (QoQ)	0.36%
Net income growth 3Y	-1.32%
Net income growth 5Y	-4.67%
Net income growth quarters	2
Net income growth years	1
OCF growth	94.2%
OCF growth 10Y	13.04%
OCF growth 3Y	-7.3%
OCF growth 5Y	11.42%
Operating income growth	12.72%
Operating income growth (Q)	15.72%
Operating income growth 3Y	10.7%
Operating income growth 5Y	7.44%
Revenue growth	7.77%
Revenue growth (Q)	6.68%
Revenue growth (QoQ)	4.63%
Revenue growth 10Y	21.97%
Revenue growth 3Y	14.9%
Revenue growth 5Y	11.11%
Revenue growth quarters	66
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-877.3M
Depreciation and amortization	$1.3B
EBIT	$8.3B
EBITDA	$9.6B
EPS	$18.20
Financing cash flow	$-1.8B
Free cash flow	$6.9B
Gross profit	$19.4B
Income taxes	$1.2B
Investing cash flow	$-4.5B
Net borrowing	$799.2M
Net cash flow	$1.5B
Net income	$4.8B
Operating income	$8.3B
Revenue	$212.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.81
Book value per share	$121.82
Debt / EBITDA	2.5
Debt / equity	0.74
Debt / FCF	3.5
Goodwill	$34.3B
Interest coverage	7.78
Long-term assets	$83B
Long-term liabilities	$44.2B
Net cash (debt)	$-18.6B
Net cash / market cap	-31.33%
Net debt / EBITDA	1.93
Net debt / equity	0.57
Net debt / FCF	2.7
Piotroski F-Score	6
Property, plant and equipment	$2.8B
Shareholders' equity	$32.3B
Tangible book value	$-22.5B
Tangible book value per share	$-85.30
Total assets	$118.4B
Total cash	$5.5B
Total debt	$24B
Total liabilities	$86.1B
WACC	5.23%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.83
Current assets	$35.4B
Current liabilities	$41.8B
Current ratio	0.85
Inventory turnover	43.44
Net working capital	$-9.8B
Quick ratio	0.69
Working capital	$-6.5B
Working capital turnover	-20.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.55%
Dividend growth	4.38%
Dividend growth (3Y)	8.77%
Dividend growth (5Y)	15.59%
Dividend growth years	5
Dividend payment date	2026-09-23
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$4.70
Dividend yield	2.11%
Ex-dividend date	2026-09-08
Last dividend	$1.56
Payout ratio	25.31%
Shareholder yield	5.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$282.75
1D price change	-0.63%
1M price change	9.89%
1M total return	9.89%
1W price change	-2.95%
1W total return	-2.95%
1Y price change	-3.85%
1Y return CAGR	-1.69%
1Y total return	-1.69%
20-day SMA	$290.43
200-day SMA	$281.33
3M price change	1.56%
3M total return	2.12%
3Y price change	-1.81%
3Y return CAGR	1.33%
3Y total return	4.05%
50-day SMA	$283.00
50-day SMA vs 200-day SMA	50over200
52-week high	$320.96
52-week high date	2026-10-23
52-week low	$239.52
52-week low date	2025-11-03
5Y price change	37.94%
5Y return CAGR	8.64%
5Y total return	51.35%
6M price change	5.71%
6M total return	6.9%
All-time high	$370.83
All-time high date	2024-09-16
All-time low	$164.65
All-time low date	2018-04-03
Average true range (ATR)	$10.17
Average volume	669.3
Beta (5Y)	0.3
Change from 52-week high	-7.65%
Change from 52-week low	23.75%
Change from all-time high	-20.07%
Change from all-time low	80.02%
Change from open	-0.91%
Day's gap	0.29%
Dollar volume	$200,956
High price	$300.28
Low price	$293.82
Monthly RSI	51.51
Open price	$299.13
Position in 52-week range	39.83%
Previous close	$298.26
Price vs 150-day SMA	4.83%
Price vs 20-day SMA	2.05%
Price vs 200-day SMA	5.36%
Price vs 50-day SMA	4.73%
Relative volume	0.98
RSI	54.85
Sharpe ratio	0.01
Sharpe ratio (3Y)	0.02
Sharpe ratio (5Y)	0.34
Sortino ratio	0.19
Sortino ratio (3Y)	0.22
Sortino ratio (5Y)	0.67
Volume	678
Weekly RSI	56.12
YTD price change	7.23%
YTD total return	9.04%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	262.9M
Shares change (QoQ)	-0.02%
Shares change (YoY)	-3.55%
Shares held by insiders	0.38%
Shares held by institutions	92.59%
Short ratio	4.1 days

Deeper analysis on LON/0A77

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0A77 report

Is a complete LON/0A77 research report available?

No complete published report is available for lon/0A77 (LON/0A77) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0A77 (LON/0A77)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0A77

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0A77 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0A77

Frequently asked questions